Search

everythinglearnresearchcommunity

for

Search:↓

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Covid-19 can cause hair loss due to immune and psychological factors.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Alopecia areata involves immune response and gene changes affecting hair loss.

PRP is effective for treating patchy alopecia areata.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Phototherapy can help treat hair loss in alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.